clofibrate has been researched along with phenformin in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (82.76) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (13.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Jain, AK; McMahon, FG; Ryan, JR | 1 |
| Verstraete, M | 1 |
| Althoff, B; Heggen, EM; Thesseling, W; Vogelberg, KH | 1 |
| Dilman, VM | 1 |
| Friedberg, SJ; Kudzma, DJ | 1 |
| Gries, FA; Koschinsky, T; Lang, PD; Lenhard, P; Vogelberg, KH; Vollmar, J; Wolfram, G | 1 |
| Vogelberg, KH | 1 |
| Bershteĭn, LM; Bobrov, IuF; Dil'man, VM; Kovaleva, IG; Tsyrlina, EV | 1 |
| Dil'man, VM; Kovaleva, IG | 1 |
| Bershteĭn, LM; Kovaleva, IG; Rozenberg, OA | 1 |
| Fearnley, GR | 2 |
| Dietel, J; Gries, FA; Vogelberg, KH | 1 |
| Chakrabarti, R; Fearnley, GR | 1 |
| Cochrane, MA; Dunnigan, MG; Kelly, A; Scott, JW | 1 |
| Baggio, G; Baiocchi, MR; Briani, G; Crepaldi, G; Fellin, R | 1 |
| Beaumont, P; Hollows, FC | 1 |
| Bagdade, JD | 1 |
| Gries, FA; Koschinsky, T; Vogelberg, KH | 1 |
| Clarke, BF; Duncan, LJ | 1 |
| Gawrońska-Szklarz, B; Kalinowski, W; Wójcicki, J | 1 |
| Berstein, LM; Buslaeva, VP; Dilman, VM; Fedorov, SN; Kondratjev, VB; Nemirovsky, VS; Nikiforov, YF; Ostroumova, MN; Poroshina, TE; Seleznev, IK; Semiglazov, VF; Tsyrlina, EV; Vasilyeva, IA | 1 |
| Cicmir, I; Heggen, ME; Vogelberg, KH | 1 |
| Bershteĭn, LM; Dil'man, VM; Ostroumova, MN; Vasil'eva, IA | 1 |
| Bershteĭn, LM; Buslaeva, VP; Kondrat'ev, VB; Ostroumova, MN; Semiglazov, VF | 1 |
4 review(s) available for clofibrate and phenformin
| Article | Year |
|---|---|
The position of long-term stimulation of the endogenous fibrinolytic system: present achievements and clinical perspectives.
Topics: Adrenocorticotropic Hormone; Anabolic Agents; Androgens; Clofibrate; Coronary Disease; Deamino Arginine Vasopressin; Drug Therapy, Combination; Female; Fibrinolysis; Fibrinolytic Agents; Glucocorticoids; Humans; Inflammation; Male; Metformin; Phenformin; Plasminogen Activators; Postoperative Complications; Sulfonylurea Compounds; Thromboembolism; Thrombophlebitis; Vascular Diseases | 1975 |
Fibrinolysis.
Topics: Aminocaproates; Anabolic Agents; Androgens; Antifibrinolytic Agents; Arterial Occlusive Diseases; Blood Platelets; Clofibrate; Drug Combinations; Ethylestrenol; Fibrin; Fibrinolysin; Fibrinolysis; Humans; Inflammation; Insulin; Methods; Phenformin; Plasminogen; Sulfonylurea Compounds | 1973 |
Therapy of the hyperlipoproteinemias.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Norethindrone; Phenformin; Triglycerides | 1972 |
Advances in the treatment of diabetes mellitus.
Topics: Blood Glucose; Chlorpropamide; Clofibrate; Diabetes Mellitus; Diabetic Coma; Diabetic Ketoacidosis; Diabetic Retinopathy; Diet Therapy; Humans; Hypoglycemia; Insulin; Kidney Transplantation; Lactates; Light Coagulation; Metformin; Methods; Pancreas Transplantation; Phenformin; Pituitary Gland; Renal Dialysis; Sulfonylurea Compounds; Tolbutamide | 1971 |
6 trial(s) available for clofibrate and phenformin
| Article | Year |
|---|---|
Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
Topics: Adult; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Diabetes Mellitus; Drug Synergism; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Hypoglycemic Agents; Lipoproteins, VLDL; Male; Middle Aged; Phenformin; Sulfonylurea Compounds; Tolbutamide; Triglycerides | 1975 |
Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
Topics: Blood Glucose; Chlorpropamide; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Drug Synergism; Glycolates; Halofenate; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Phenformin; Tolazamide; Tolbutamide | 1977 |
[Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
Topics: Adult; Body Weight; Cholesterol; Clofibrate; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Male; Middle Aged; Phenformin; Placebos; Triglycerides | 1977 |
[Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Clofibrate; Drug Combinations; Humans; Hyperlipidemias; Male; Middle Aged; Phenformin; Triglycerides | 1976 |
[Control of the effectiveness of the hypolipidemic effects of miscleron and phenformin].
Topics: Anticholesteremic Agents; Blood Platelets; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Lymphocytes; Male; Phenformin | 1991 |
[The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
Topics: Adult; Biguanides; Body Weight; Clofibrate; Diabetes Mellitus; Enzymes; Female; Humans; Hypoglycemic Agents; Lactates; Lipids; Male; Middle Aged; Phenformin; Triglycerides | 1980 |
19 other study(ies) available for clofibrate and phenformin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
Topics: Cholesterol; Clofibrate; Drug Therapy, Combination; Humans; Hyperlipidemias; Lipoproteins, LDL; Phenformin; Triglycerides | 1976 |
Ageing, metabolic immunodepression and carcinogenesis.
Topics: Adult; Aged; Aging; Cell Transformation, Neoplastic; Cholesterol; Clofibrate; Coronary Disease; Diabetes Mellitus; Energy Metabolism; Fatty Acids, Nonesterified; Female; Humans; Hypothalamo-Hypophyseal System; Immunity, Cellular; Immunologic Deficiency Syndromes; Insulin; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Neoplasms; Phenformin; Pregnancy; Triglycerides | 1978 |
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin].
Topics: Adrenal Cortex Hormones; Aged; Biguanides; Blood Glucose; Body Weight; Breast Neoplasms; Buformin; Cholesterol; Clofibrate; Colonic Neoplasms; Endocrine System Diseases; Fatty Acids; Female; Growth Hormone; Humans; Insulin; Lipoproteins; Lung Neoplasms; Middle Aged; Neoplasms; Phenformin; Phenytoin; Phospholipids; Triglycerides; Uric Acid; Uterine Neoplasms | 1975 |
[Effect of hypolipidemic preparations on basal and stimulated adenylate cyclase activity in tumor cells].
Topics: Adenylyl Cyclases; Animals; Carcinoma, Ehrlich Tumor; Clofibrate; Enzyme Activation; Epinephrine; Hypolipidemic Agents; Lipid Metabolism; Male; Mice; Phenformin; Phosphatidylcholines | 1985 |
[Clinical picture and treatment of insulin resistance in primary hyperlipoproteinaemia (author's transl)].
Topics: Blood Glucose; Blood Protein Disorders; Chromatography, Thin Layer; Clofibrate; Diabetes Complications; Female; Humans; Insulin Resistance; Lipoproteins, VLDL; Middle Aged; Phenformin; Triglycerides | 1973 |
Pharmacological fibrinolysis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Clofibrate; Delayed-Action Preparations; Drug Resistance; Drug Therapy, Combination; Ethylestrenol; Female; Fibrin; Fibrinolysis; Humans; Male; Metformin; Methadone; Nandrolone; Phenformin; Stimulation, Chemical; Sulfonylurea Compounds; Testosterone; Time Factors | 1972 |
Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
Topics: Adult; Chlorpropamide; Cholesterol; Clofibrate; Diabetes Mellitus; Dietary Carbohydrates; Female; Genes, Dominant; Humans; Hyperlipidemias; Insulin; Lipodystrophy; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Pedigree; Phenformin; Triglycerides | 1974 |
[Treatment of hyperlipoproteinemias (author's transl)].
Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Ion Exchange Resins; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metformin; Middle Aged; Nicotinic Acids; Phenformin | 1974 |
Types of diabetic retinopathy and treatment.
Topics: Adult; Clofibrate; Diabetic Retinopathy; Ethylestrenol; Fluorescein Angiography; Humans; Medroxyprogesterone; Ophthalmoscopy; Phenformin | 1973 |
[Biguanide therapy of primary hyperlipoproteinemias type IIb, 3 and IV as monotherapy and combined with clofibrate].
Topics: Adult; Aged; Biguanides; Clofibrate; Drug Combinations; Humans; Hyperlipidemias; Middle Aged; Phenformin | 1973 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation Tests; Blood Platelets; Clofibrate; Coronary Disease; Diabetes Mellitus; Ethylestrenol; Fibrinolysis; Humans; Insulin; Metformin; Myocardial Infarction; Phenformin; Sulfonylurea Compounds; Testosterone; Thrombosis | 1971 |
[Effect of hypertriglyceridemia and its treatment on tetracycline pharmacokinetics].
Topics: Adult; Clofibrate; Doxycycline; Drug Interactions; Humans; Hyperlipoproteinemia Type IV; Kinetics; Male; Middle Aged; Oxytetracycline; Phenformin; Triglycerides | 1984 |
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances.
Topics: Age Factors; Body Weight; Breast Neoplasms; Clofibrate; Female; Hormones; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Leukocyte Count; Lipids; Lymphocyte Activation; Mastectomy; Middle Aged; Phenformin; Time Factors | 1982 |
[Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Clofibrate; Female; Humans; Hyperlipidemias; Middle Aged; Phenformin; Somatomedins; Uterine Neoplasms | 1980 |
[Effect of fenformin and miscleron on the delayed hypersensitivity reaction in breast cancer patients].
Topics: Breast Neoplasms; Clofibrate; Dinitrochlorobenzene; Drug Therapy, Combination; Female; Humans; Hypersensitivity, Delayed; Hypolipidemic Agents; Middle Aged; Phenformin; Skin Tests; Time Factors | 1980 |